A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer

Investigational New Drugs

Volumn 33, Issue 2, 2015, Pages 480-489

  Alumkal, Joshi J ^a   Slottke, Rachel ^a   Schwartzman, Jacob ^a   Cherala, Ganesh ^a   Munar, Myrna ^a   Graff, Julie N ^a   Beer, Tomasz M ^a   Ryan, Christopher W ^a   Koop, Dennis R ^a   Gibbs, Angela ^a   Gao, Lina ^a   Flamiatos, Jason F ^a   Tucker, Erin ^a   Kleinschmidt, Richard ^a   Mori, Motomi ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Biochemical recurrence; Prostate cancer; Sulforaphane

Indexed keywords

GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; ISOTHIOCYANIC ACID DERIVATIVE; PLANT EXTRACT; PROSTATE SPECIFIC ANTIGEN; SULFORAFAN;

AREA UNDER THE CURVE; BRASSICA; CHEMISTRY; CLINICAL TRIAL; DOSE RESPONSE; GENETICS; HALF LIFE TIME; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLIC CLEARANCE RATE; PHASE 2 CLINICAL TRIAL; PROSTATIC NEOPLASMS; TANDEM MASS SPECTROMETRY; TUMOR RECURRENCE;

AREA UNDER CURVE; BRASSICA; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE TRANSFERASE; HALF-LIFE; HUMANS; ISOTHIOCYANATES; MALE; METABOLIC CLEARANCE RATE; NEOPLASM RECURRENCE, LOCAL; PLANT EXTRACTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TANDEM MASS SPECTROMETRY;

EID: 84939538926     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-014-0189-z     Document Type: Article

References (33)

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA: A Cancer J Clin 64(1):9-29. doi: 10.3322/caac.21208
2. Cohen JH, Kristal AR, Stanford JL (2000) Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst 92(1):61-68
3. Kristal AR, Lampe JW (2002) Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer 42(1):1-9. doi: 10.1207/S15327914NC421-1
4. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB (2007) Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst 99(15):1200-1209. doi: 10.1093/jnci/djm065
5. Traka M, Gasper AV, Melchini A, Bacon JR, Needs PW, Frost V, Chantry A, Jones AM, Ortori CA, Barrett DA, Ball RY, Mills RD, Mithen RF (2008) Broccoli consumption interacts with GSTM1 to perturb oncogenic signalling pathways in the prostate. PLoS One 3(7):e2568. doi: 10.1371/journal.pone.0002568
6. Zhang Y, Talalay P, Cho CG, Posner GH (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci U S A 89(6):2399-2403
7. Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E (2006) Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinog 27(4):811-819. doi: 10.1093/carcin/bgi265
8. Singh SV, Warin R, Xiao D, Powolny AA, Stan SD, Arlotti JA, Zeng Y, Hahm ER, Marynowski SW, Bommareddy A, Desai D, Amin S, Parise RA, Beumer JH, Chambers WH (2009) Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells. Cancer Res 69(5):2117-2125. doi: 10.1158/0008-5472.CAN-08-3502
9. Gibbs A, Schwartzman J, Deng V, Alumkal J (2009) Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. Proc Natl Acad Sci U S A 106(39):16663-16668. doi: 10.1073/pnas.0908908106
10. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E (2007) Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med 232(2):227-234
11. Myzak MC, Karplus PA, Chung FL, Dashwood RH (2004) A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64(16):5767-5774. doi: 10.1158/0008-5472.CAN-04-1326
12. Zhang Y, Kolm RH, Mannervik B, Talalay P (1995) Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem Biophys Res Commun 206(2):748-755
13. Seidegard J, Vorachek WR, Pero RW, Pearson WR (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 85(19):7293-7297
14. Brennan P, Hsu CC, Moullan N, Szeszenia-Dabrowska N, Lissowska J, Zaridze D, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Gemignani F, Chabrier A, Hall J, Hung RJ, Boffetta P, Canzian F (2005) Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet 366(9496):1558-1560. doi: 10.1016/S0140-6736(05)67628-3
15. Joseph MA, Moysich KB, Freudenheim JL, Shields PG, Bowman ED, Zhang Y, Marshall JR, Ambrosone CB (2004) Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr Cancer 50(2):206-213. doi: 10.1207/s15327914nc5002-11
16. Gasper AV, Al-Janobi A, Smith JA, Bacon JR, Fortun P, Atherton C, Taylor MA, Hawkey CJ, Barrett DA, Mithen RF (2005) Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 82(6):1283-1291
17. Riedl MA, Saxon A, Diaz-Sanchez D (2009) Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 130(3):244-251. doi: 10.1016/j.clim.2008.10.007
18. Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, Ye L, Coady JL, Wang JB, Wu Y, Sun Y, Zhang QN, Zhang BC, Zhu YR, Qian GS, Carmella SG, Hecht SS, Benning L, Gange SJ, Groopman JD, Talalay P (2005) Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 14(11 Pt 1):2605-2613. doi: 10.1158/1055-9965.EPI-05-0368
19. Scher HI, Halabi S, Tannock I, Morris M, Sternberg CN, Carducci MA, Eisenberger MA, Higano C, Bubley GJ, Dreicer R, Petrylak D, Kantoff P, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M, Prostate Cancer Clinical Trials Working G (2008) Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the prostate cancer clinical trials working group. J Clin Oncol: Off J Am Soc Clin Oncol 26(7):1148-1159. doi: 10.1200/JCO.2007.12.4487
20. Timofeeva M, Jager B, Rosenberger A, Sauter W, Wichmann HE, Group KS, Bickeboller H, Risch A (2009) A multiplex real-time PCR method for detection of GSTM1 and GSTT1 copy numbers. Clin Biochem 42(6):500-509. doi: 10.1016/j.clinbiochem.2008.12.011
21. Dinkova-Kostova AT, Fahey JW, Benedict AL, Jenkins SN, Ye L, Wehage SL, Talalay P (2010) Dietary glucoraphanin-rich broccoli sprout extracts protect against UV radiation-induced skin carcinogenesis in SKH-1 hairless mice. Photochem Photobiol Sci: Off J Eur Photochem Assoc Eur Soc Photobiol 9(4):597-600. doi: 10.1039/b9pp00130a
22. Egner PA, Chen JG, Wang JB, Wu Y, Sun Y, Lu JH, Zhu J, Zhang YH, Chen YS, Friesen MD, Jacobson LP, Munoz A, Ng D, Qian GS, Zhu YR, Chen TY, Botting NP, Zhang Q, Fahey JW, Talalay P, Groopman JD, Kensler TW (2011) Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev Res (Phila) 4(3):384-395. doi: 10.1158/1940-6207.CAPR-10-0296
23. Shapiro TA, Fahey JW, Dinkova-Kostova AT, Holtzclaw WD, Stephenson KK, Wade KL, Ye L, Talalay P (2006) Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr Cancer 55(1):53-62. doi: 10.1207/s15327914nc5501-7
24. Tang L, Zhang Y, Jobson HE, Li J, Stephenson KK, Wade KL, Fahey JW (2006) Potent activation of mitochondria-mediated apoptosis and arrest in S and M phases of cancer cells by a broccoli sprout extract. Mol Cancer Ther 5(4):935-944. doi: 10.1158/1535-7163.MCT-05-0476
25. Zhang Y, Wade KL, Prestera T, Talalay P (1996) Quantitative determination of isothiocyanates, dithiocarbamates, carbon disulfide, and related thiocarbonyl compounds by cyclocondensation with 1,2-benzenedithiol. Anal Biochem 239(2):160-167. doi: 10.1006/abio.1996.0311
26. Wade KL, Garrard IJ, Fahey JW (2007) Improved hydrophilic interaction chromatography method for the identification and quantification of glucosinolates. J Chromatogr A 1154(1-2):469-472. doi: 10.1016/j.chroma.2007.04.034
27. Fahey JW, Dinkova-Kostova AT, Stephenson KK, Talalay P (2004) The "Prochaska" microtiter plate bioassay for inducers of NQO1. Methods Enzymol 382:243-258. doi: 10.1016/S0076-6879(04)82014-7
28. Al Janobi AA, Mithen RF, Gasper AV, Shaw PN, Middleton RJ, Ortori CA, Barrett DA (2006) Quantitative measurement of sulforaphane, iberin and their mercapturic acid pathway metabolites in human plasma and urine using liquid chromatography-tandem electrospray ionisation mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 844(2):223-234. doi: 10.1016/j.jchromb.2006.07.007
29. Clarke JD, Hsu A, Williams DE, Dashwood RH, Stevens JF, Yamamoto M, Ho E (2011) Metabolism and tissue distribution of sulforaphane in Nrf2 knockout and wild-type mice. Pharm Res 28(12):3171-3179. doi: 10.1007/s11095-011-0500-z
30. Rowland M, Tozer TN (1980) Clinical pharmacokinetics: concepts and applications. Lea & Febiger, Philadelphia
31. Smith MR, Manola J, Kaufman DS, Oh WK, Bubley GJ, Kantoff PW (2006) Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy. J Clin Oncol: Off J Am Soc Clin Oncol 24(18):2723-2728. doi: 10.1200/JCO.2005.03.7804
32. Smith MR, Manola J, Kaufman DS, George D, Oh WK, Mueller E, Slovin S, Spiegelman B, Small E, Kantoff PW (2004) Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy. Cancer 101(7):1569-1574. doi: 10.1002/cncr.20493
33. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA: J Am Med Assoc 294(4):433-439. doi: 10.1001/jama.294.4.433